EAACI Task force Clinical epidemiology of anaphylaxis: experts ’ perspective on the use of adrenaline autoinjectors in Europe

ConclusionOur data confirm the lack of consensus regarding the number of AAIs to prescribe. Despite the European Medical Agency recommendation, the majority of allergy experts prescribed one autoinjector per patient. However, under distinct circumstances (e.g. mastocytosis, asthma, excess body weight, a history of severe anaphylaxis, or restricted access to immediate emergency), experts tended to prescribe more AAIs, which is in accordance with the European Academy of Allergy and Clinical Immunology guidelines.
Source: Clinical and Translational Allergy - Category: Allergy & Immunology Source Type: research